BCR-ABL1-positive CML and BCR-ABL1-negative chronic myeloproliferative disorders: Some common and contrasting features

N. C.P. Cross; G. Q. Daley; A. R. Green; T. P. Hughes; C. Jamieson; P. Manley; T. Mughal; D. Perrotti; J. Radich; R. Skoda; S. Soverini; W. Vainchenker; S. Verstovsek; J. L. Villeval; J. M. Goldman

doi:10.1038/leu.2008.231

BCR-ABL1-positive CML and BCR-ABL1-negative chronic myeloproliferative disorders: Some common and contrasting features

N. C.P. Cross, G. Q. Daley, A. R. Green, T. P. Hughes, C. Jamieson, P. Manley, T. Mughal, D. Perrotti, J. Radich, R. Skoda, S. Soverini, W. Vainchenker, S. Verstovsek, J. L. Villeval, J. M. Goldman

Leukemia

Research output: Contribution to journal › Editorial › peer-review

17 Scopus citations

Original language	English (US)
Pages (from-to)	1975-1989
Number of pages	15
Journal	Leukemia
Volume	22
Issue number	11
DOIs	https://doi.org/10.1038/leu.2008.231
State	Published - 2008

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1038/leu.2008.231

Cite this

Cross, N. C. P., Daley, G. Q., Green, A. R., Hughes, T. P., Jamieson, C., Manley, P., Mughal, T., Perrotti, D., Radich, J., Skoda, R., Soverini, S., Vainchenker, W., Verstovsek, S., Villeval, J. L., & Goldman, J. M. (2008). BCR-ABL1-positive CML and BCR-ABL1-negative chronic myeloproliferative disorders: Some common and contrasting features. Leukemia, 22(11), 1975-1989. https://doi.org/10.1038/leu.2008.231

Cross, NCP, Daley, GQ, Green, AR, Hughes, TP, Jamieson, C, Manley, P, Mughal, T, Perrotti, D, Radich, J, Skoda, R, Soverini, S, Vainchenker, W, Verstovsek, S, Villeval, JL & Goldman, JM 2008, 'BCR-ABL1-positive CML and BCR-ABL1-negative chronic myeloproliferative disorders: Some common and contrasting features', Leukemia, vol. 22, no. 11, pp. 1975-1989. https://doi.org/10.1038/leu.2008.231

@article{66d603af975f487791c06077b2d80ee6,

title = "BCR-ABL1-positive CML and BCR-ABL1-negative chronic myeloproliferative disorders: Some common and contrasting features",

author = "Cross, {N. C.P.} and Daley, {G. Q.} and Green, {A. R.} and Hughes, {T. P.} and C. Jamieson and P. Manley and T. Mughal and D. Perrotti and J. Radich and R. Skoda and S. Soverini and W. Vainchenker and S. Verstovsek and Villeval, {J. L.} and Goldman, {J. M.}",

note = "Funding Information: This report was based on a workshop that took place in Puerto Rico on 12 and 13 December 2007, but it includes some data that became available after that date. The participants at the meeting in Puerto Rico included: Tiziano Barbui, Bergamo, Italy; Giovanni Barosi, Pavia, Italy; Nicholas Cross, Salisbury, UK; Alan Gewirtz, Philadelphia, USA; Sergio Giralt, Houston, USA; John Goldman, London, UK; Anthony Green, Cambridge, UK; Oliver Hantschel, Vienna, Austria; Jonathan Harris, Philadelphia, USA; Ronald Hoffmann, New York, USA; Rudiger Hehlmann, Mannheim, Germany; Timothy Hughes, Adelaide, Australia; Catriona Jamieson, San Diego, USA; Pierre Laneu-ville, Montreal, Canada, Francis Lee (Bristol Myers Squibb, Wallingford, CT, USA); Ross Levine, Boston, USA; Paul Manley (Novartis), Junia Melo, London, UK; Tariq Mughal, Dallas, USA; Heike Pahl, Freiburg, Germany; Feyruz Rassool, Baltimore, USA; Giuseppe Saglio, Torino, Italy; Richard Silver, New York, USA; Radek Skoda, Basel, Switzerland; Ted Szatrowki (Bristol-Myers Squibb), William Vainchenker, Paris, France; Richard van Etten, Boston, USA; Alessandro Vannucchi, (Florence, Italy), Jean Luc Villeval, Paris, France; Richard Woodman (Novartis), The meeting was supported by unrestricted educational grants from Bristol-Myers Squibb, Novartis Pharmaceuticals and Wyeth Pharmaceuticals.",

year = "2008",

doi = "10.1038/leu.2008.231",

language = "English (US)",

volume = "22",

pages = "1975--1989",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "11",

}

TY - JOUR

T1 - BCR-ABL1-positive CML and BCR-ABL1-negative chronic myeloproliferative disorders

T2 - Some common and contrasting features

AU - Cross, N. C.P.

AU - Daley, G. Q.

AU - Green, A. R.

AU - Hughes, T. P.

AU - Jamieson, C.

AU - Manley, P.

AU - Mughal, T.

AU - Perrotti, D.

AU - Radich, J.

AU - Skoda, R.

AU - Soverini, S.

AU - Vainchenker, W.

AU - Verstovsek, S.

AU - Villeval, J. L.

AU - Goldman, J. M.

N1 - Funding Information: This report was based on a workshop that took place in Puerto Rico on 12 and 13 December 2007, but it includes some data that became available after that date. The participants at the meeting in Puerto Rico included: Tiziano Barbui, Bergamo, Italy; Giovanni Barosi, Pavia, Italy; Nicholas Cross, Salisbury, UK; Alan Gewirtz, Philadelphia, USA; Sergio Giralt, Houston, USA; John Goldman, London, UK; Anthony Green, Cambridge, UK; Oliver Hantschel, Vienna, Austria; Jonathan Harris, Philadelphia, USA; Ronald Hoffmann, New York, USA; Rudiger Hehlmann, Mannheim, Germany; Timothy Hughes, Adelaide, Australia; Catriona Jamieson, San Diego, USA; Pierre Laneu-ville, Montreal, Canada, Francis Lee (Bristol Myers Squibb, Wallingford, CT, USA); Ross Levine, Boston, USA; Paul Manley (Novartis), Junia Melo, London, UK; Tariq Mughal, Dallas, USA; Heike Pahl, Freiburg, Germany; Feyruz Rassool, Baltimore, USA; Giuseppe Saglio, Torino, Italy; Richard Silver, New York, USA; Radek Skoda, Basel, Switzerland; Ted Szatrowki (Bristol-Myers Squibb), William Vainchenker, Paris, France; Richard van Etten, Boston, USA; Alessandro Vannucchi, (Florence, Italy), Jean Luc Villeval, Paris, France; Richard Woodman (Novartis), The meeting was supported by unrestricted educational grants from Bristol-Myers Squibb, Novartis Pharmaceuticals and Wyeth Pharmaceuticals.

PY - 2008

Y1 - 2008

UR - http://www.scopus.com/inward/record.url?scp=56349129388&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56349129388&partnerID=8YFLogxK

U2 - 10.1038/leu.2008.231

DO - 10.1038/leu.2008.231

M3 - Editorial

C2 - 19002192

AN - SCOPUS:56349129388

SN - 0887-6924

VL - 22

SP - 1975

EP - 1989

JO - Leukemia

JF - Leukemia

IS - 11

ER -

BCR-ABL1-positive CML and BCR-ABL1-negative chronic myeloproliferative disorders: Some common and contrasting features

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this